Hims & Hers Health Inc - Class A (HIMS) Stock

Hims & Hers Health Inc - Class A Stock Details, Movements and Public Alerts

Stock Details

Hims & Hers Health Inc - Class A (HIMS), a prominent company in the life sciences sector within the services-offices & clinics of doctors of medicine industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $56.67. Over the past 52 weeks, it has ranged between $13.47 and $72.98. This places the current price at 77.7% of its 52-week high and 320.7% above its 52-week low. Recent trading volume was recorded at 6,877. The 14-day Relative Strength Index (RSI) stands at 58.25, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $41.89 by 35.28%. Similarly, it is above its 200-day moving average of $31.40 by 80.48%. The MACD histogram is -1.15, indicating bearish momentum (MACD Line: 3.07, Signal Line: 4.22). There is currently 1 active alert set for HIMS by users.

52-Week High

$72.98

52-Week Low

$13.47

Volume

6,877

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

83.18

Above market average

Forward P/E

93.46

Earnings expected to decline

PEG Ratio

5.25

Potentially overvalued

Price to Book

23.05

EV/EBITDA

93.76

EPS (TTM)

$0.68

Price to Sales

7.09

Beta

1.85

More volatile than market

Is HIMS's P/E ratio considered high or low?
Hims & Hers Health Inc - Class A's current P/E ratio is 83.18, which is above the market average. This typically suggests investors expect higher future growth, or it could mean the stock is relatively expensive compared to its current earnings.
How does HIMS's Forward P/E compare to its current P/E?
Hims & Hers Health Inc - Class A's current P/E is 83.18 and its Forward P/E is 93.46. The higher Forward P/E suggests analysts expect earnings might decline or grow more slowly in the coming year.
What does HIMS's PEG ratio tell investors?
Hims & Hers Health Inc - Class A's PEG ratio is 5.25. A PEG ratio above 2.0 might suggest the stock is overvalued relative to its expected growth rate.
How volatile is HIMS compared to the overall market?
Hims & Hers Health Inc - Class A's beta value is 1.85. A beta above 1.5 indicates significantly higher volatility than the market. This stock may experience larger price swings in both directions.

Performance & Growth

Profit Margin

9.21%

Operating Margin

10.10%

Return on Equity

36.80%

Return on Assets

10.80%

Revenue Growth (YoY)

110.70%

Earnings Growth (YoY)

313.60%

How profitable is HIMS compared to its industry peers?
Hims & Hers Health Inc - Class A has a profit margin of 9.21%. This is a solid profit margin in line with healthy businesses. It indicates the company retains $9.21 as profit for every $100 in revenue. Profit margins vary by industry, and SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE companies typically need to be evaluated against their specific sector benchmarks.
What do HIMS's ROE and ROA figures tell investors?
Hims & Hers Health Inc - Class A has a Return on Equity (ROE) of 36.80% and a Return on Assets (ROA) of 10.80%. The ROE is strong, indicating efficient use of shareholders' equity to generate profits. The ROA is healthy, suggesting management is effectively using company assets to generate earnings. The large gap between ROE and ROA suggests the company has significant leverage (debt), which amplifies returns but potentially increases risk.
Is HIMS growing faster or slower than in previous periods?
Hims & Hers Health Inc - Class A's year-over-year quarterly revenue growth is 110.70%. This represents robust revenue growth significantly above market averages. Meanwhile, earnings growth is 313.60% year-over-year. Earnings are growing faster than revenue, suggesting improving profit margins or operational efficiency.
What does HIMS's operating margin tell us about its business model?
Hims & Hers Health Inc - Class A's operating margin is 10.10%. This represents a healthy operating margin that shows the company is effectively managing its core operational costs relative to revenue. Operating margins vary widely by industry, and in the services-offices & clinics of doctors of medicine sector, this margin should be evaluated relative to industry peers.

Company Size & Market

Market Cap

$12.66B

Shares Outstanding

215.45M

Book Value/Share

$2.46

Asset Type

Common Stock

What does HIMS's market capitalization tell investors?
Hims & Hers Health Inc - Class A's market capitalization is $12.66B, which makes it a large-cap company. Large-caps are generally considered more stable investments with established business models and often pay regular dividends. Within the services-offices & clinics of doctors of medicine industry, this market cap places Hims & Hers Health Inc - Class A among the significant companies in the industry.
What's the significance of HIMS's book value per share?
Hims & Hers Health Inc - Class A's book value per share is $2.46, while its current market price is $56.67. This gives a price-to-book (P/B) ratio of 23.06. This relatively high P/B ratio indicates investors are willing to pay a significant premium over the accounting value of the company's equity, typically due to strong growth prospects, high returns on equity, or valuable intangible assets not fully reflected on the balance sheet. In the services-offices & clinics of doctors of medicine industry, this P/B ratio should be compared to industry peers for context.
How does the number of outstanding shares affect HIMS investors?
Hims & Hers Health Inc - Class A has 215.45M outstanding shares. The number of outstanding shares directly affects metrics like earnings per share (EPS) and can be influenced by corporate actions such as stock splits, buybacks, or new share issuances. With a market cap of $12.66B, each share represents ownership of approximately $58.76 of the company's total value. When companies reduce their outstanding shares through buyback programs, this can increase EPS and potentially support higher share prices, assuming other factors remain constant. Conversely, when new shares are issued, this can dilute existing shareholders' ownership stakes.

Analyst Ratings

Analyst Target Price

$47.56

16.08% downside potential

Analyst Recommendations

Strong Buy

1

Buy

3

Hold

8

Sell

1

Strong Sell

1

How should I interpret analysts' recommendations for HIMS?
For Hims & Hers Health Inc - Class A, analysts have provided the following recommendations: 1 Strong Buy, 3 Buy, 8 Hold, 1 Sell, 1 Strong Sell. Analyst recommendations reflect professional opinions about a stock's potential performance, but they should be just one factor in your investment decisions. Each analyst may use different methodologies and timeframes for their assessments. Overall, analysts currently have a positive view on this stock.
What does the analyst target price mean for HIMS?
The consensus analyst target price for Hims & Hers Health Inc - Class A is $47.56, compared to its current price of $56.67. This represents a potential downside of 16.08%. Analyst target prices typically reflect where professionals expect the stock price to be in 12 months. This consensus target is derived from individual price targets set by various analysts covering the stock, and it may be updated as market conditions change or as new information becomes available. Keep in mind that while target prices provide insight into professional expectations, they are not guarantees, and actual price performance can vary significantly from these targets.
How accurate are analyst forecasts for stocks like HIMS?
Analyst forecasts, while informative, have inherent limitations in their accuracy. Studies have shown that analysts' predictions can be influenced by various biases, including optimism bias (tendency to be overly positive) and herding behavior (following other analysts' opinions). In the services-offices & clinics of doctors of medicine industry, forecasts may be particularly challenging due to factors like changing market conditions, competitive dynamics, regulatory changes, and macroeconomic shifts.
Historically, analysts have been more accurate when forecasting:
  • Stable, mature companies with predictable earnings
  • Near-term results rather than long-term performance
  • Companies with transparent business models
Consider analyst forecasts as one tool among many in your investment research, and evaluate them alongside other metrics, industry trends, and your own assessment of the company's fundamentals and market position.

Fundamentals last updated: Jun 2, 2025, 01:07 PM

Technical Indicators

RSI (14-day)

58.25

Neutral

50-Day Moving Average

$41.89

35.28% above MA-50

200-Day Moving Average

$31.40

80.48% above MA-200

MACD Line

3.07

MACD Signal

4.22

MACD Histogram

-1.15

Bearish

What does HIMS's RSI value tell investors?
Hims & Hers Health Inc - Class A's current Relative Strength Index (RSI) is 58.25. This indicates neutral momentum as the RSI is in the middle range. Values around 50 suggest no clear directional bias. The RSI is a momentum oscillator that measures the speed and change of price movements on a scale from 0 to 100. It's used to identify overbought or oversold conditions and potential reversals.
How should I interpret HIMS's moving averages?
Hims & Hers Health Inc - Class A's current price of $56.67 is above both its 50-day moving average ($41.89) and its 200-day moving average ($31.40). This is typically considered bullish, indicating the stock is in an uptrend across both short and long-term timeframes. Additionally, the 50-day moving average is above the 200-day moving average, forming what traders call a 'golden cross,' which is generally considered a bullish signal. Moving averages smooth out price data to create a single flowing line, making it easier to identify the direction of the trend. The 50-day MA represents medium-term trend, while the 200-day MA reflects the long-term trend.
What is the MACD indicating about HIMS's momentum?
For Hims & Hers Health Inc - Class A, the MACD Line is 3.07, the Signal Line is 4.22, and the MACD Histogram is -1.15. The negative MACD histogram indicates bearish momentum, with the MACD line below the signal line. This suggests selling pressure is currently stronger than buying pressure. The MACD (Moving Average Convergence Divergence) is a trend-following momentum indicator that shows the relationship between two moving averages of a security's price. The MACD line is calculated by subtracting the 26-period EMA from the 12-period EMA. The signal line is a 9-period EMA of the MACD line, and the histogram represents the difference between the MACD line and the signal line.

Indicators last updated: Jun 9, 2025, 12:00 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$30.00
Created
Jun 2, 2025, 01:05 PM

Stay Ahead of the Market with Hims & Hers Health Inc - Class A Alerts

Set up price alerts for Hims & Hers Health Inc - Class A and get notified instantly when the price hits your target. Never miss an important price movement again.